The first reported case of pseudoparathryoidism type IB in Hong Kong: hypocalcemia in an adolescent boy with recurrent s

  • PDF / 333,779 Bytes
  • 1 Pages / 595.28 x 793.7 pts Page_size
  • 72 Downloads / 142 Views

DOWNLOAD

REPORT


POSTER PRESENTATION

Open Access

The first reported case of pseudoparathryoidism type IB in Hong Kong: hypocalcemia in an adolescent boy with recurrent seizures Antony CC Fu1*, Kwok-lap Chan2, Luke Chi-tak Tong2 From 7th APPES Biennial Scientific Meeting Nusa Dua, Bali. 14-17 November 2012

Pseudohypoparathyroidism (PHP) is a heterogeneous group of disorders characterized by hypocalcemia, hyperphoshatemia and inappropriately elevated serum parathyroid hormone (PTH) level due to end-organ resistance of biological activity of parathyroid hormone. It is due to epigenetic change at the GNAS locus and is divided into types Ia, Ib, Ic and II. We hereby describe the first reported case of pseudohypoparathyroidism type Ib Hong Kong. Authors’ details 1 Department of Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong. 2Department of Paediatrics, Alice Ho Miu Ling Nethersole Hospital. Published: 3 October 2013

doi:10.1186/1687-9856-2013-S1-P157 Cite this article as: Fu et al.: The first reported case of pseudoparathryoidism type IB in Hong Kong: hypocalcemia in an adolescent boy with recurrent seizures. International Journal of Pediatric Endocrinology 2013 2013(Suppl 1):P157.

Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution 1 Department of Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Full list of author information is available at the end of the article

Submit your manuscript at www.biomedcentral.com/submit

© 2013 Fu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.